Literature DB >> 23793103

Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.

Ki-Wug Sung1, Sang June Hahn.   

Abstract

Mosapride and cisapride are gastroprokinetic agents with 5-hydroxytryptamine4 receptor agonist activity and have been widely used in the treatment of a variety of gastrointestinal disorders. The effects of mosapride and cisapride on cloned Kv4.3 channels stably expressed in Chinese hamster ovary cells were investigated using the whole-cell patch-clamp technique. Mosapride and cisapride inhibited Kv4.3 in a concentration-dependent manner with IC50 values of 15.2 and 9.8 μM, respectively. Mosapride accelerated the rate of inactivation and activation of Kv4.3 in a concentration-dependent manner and thereby decreased the time to peak. The rate constants of association (k +1) and dissociation (k -1) for mosapride were 9.9 μM(-1) s(-1) and 151.3 s(-1), respectively. The K D (k -1/k +1) was 16.2 μM, similar to the IC50 value calculated from the concentration-response curve. Voltage-dependent inhibition by mosapride was observed in the voltage range for channel opening but was not observed over a voltage range in which all Kv4.3 channels were open. Both the steady-state activation and inactivation curves of Kv4.3 were shifted in the hyperpolarizing direction in the presence of mosapride. Mosapride also caused a substantial acceleration in closed-state inactivation of Kv4.3. Mosapride produced use-dependent inhibition, which was consistent with a slow recovery from inactivation of Kv4.3. M1 and norcisapride, the major metabolites of mosapride and cisapride, respectively, had little or no effect on Kv4.3. These results indicate that mosapride inhibits Kv4.3 by both preferential binding to the open state of the channels during depolarization and acceleration of the closed-state inactivation at subthreshold potentials.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793103     DOI: 10.1007/s00210-013-0896-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  53 in total

Review 1.  A-type potassium currents in smooth muscle.

Authors:  Gregory C Amberg; Sang Don Koh; Yuji Imaizumi; Susumu Ohya; Kenton M Sanders
Journal:  Am J Physiol Cell Physiol       Date:  2003-03       Impact factor: 4.249

2.  AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.

Authors:  N Yoshida; T Ito; T Karasawa; Z Itoh
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

Review 3.  The hERG potassium channel as a therapeutic target.

Authors:  Harry J Witchel
Journal:  Expert Opin Ther Targets       Date:  2007-03       Impact factor: 6.902

4.  Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current.

Authors:  J E Dixon; W Shi; H S Wang; C McDonald; H Yu; R S Wymore; I S Cohen; D McKinnon
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

5.  Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.

Authors:  R E Pearce; R R Gotschall; G L Kearns; J S Leeder
Journal:  Drug Metab Dispos       Date:  2001-12       Impact factor: 3.922

6.  Contribution of Kv4 channels toward the A-type potassium current in murine colonic myocytes.

Authors:  Gregory C Amberg; Sang Don Koh; William J Hatton; Keith J Murray; Kevin Monaghan; Burton Horowitz; Kenton M Sanders
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

7.  Transient outward current in opossum esophageal circular muscle.

Authors:  H I Akbarali; N Hatakeyama; Q Wang; R K Goyal
Journal:  Am J Physiol       Date:  1995-06

Review 8.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

9.  Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.

Authors:  S Matsumoto; K Yoshida; A Itogawa; M Tagawa; T Fujii; H Miyazaki; Y Sekine
Journal:  Arzneimittelforschung       Date:  1993-10

10.  Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.

Authors:  S Matsumoto; M Tagawa; T Hatoyama; T Fujii; H Miyazaki; Y Sekine
Journal:  Arzneimittelforschung       Date:  1993-10
View more
  1 in total

Review 1.  Disorders of gastrointestinal hypomotility.

Authors:  Klaus Bielefeldt; Ashok Tuteja; Salman Nusrat
Journal:  F1000Res       Date:  2016-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.